Navigation Links
Developing a new vaccine using a new technology

The International AIDS Vaccine Initiative (IAVI) together with GlaxoSmithKline Biologicals// (GSK Biologicals) have announced a public-private partnership to develop an AIDS vaccine using a new technology. The human primate adenovirus vector technology was derived from research conducted by scientists at the University of Pennsylvania. The technology is owned by the University and is exclusively licensed to GSK.

According to the agreement, IAVI and GSK will collaborate to advance the development of the technology, which uses non-infectious vaccine vectors to stimulate specific immune responses directed against HIV, the virus that causes AIDS. The vectors are derived from adenoviruses, originally isolated from non-human primates, which have been engineered to be non-infectious and capable of efficiently delivering genes expressing HIV proteins to the immune system. IAVI will play a role in contributing technical expertise and funding and thus form a joint R&D team together with GSK.

Members of the team say that the initial research will focus on designing vaccines to elicit immune responses against variants of HIV that circulate predominantly in Africa and after pre-clinical evaluation, GSK Biologicals and IAVI plan to conduct Phase I clinical trials of the vaccine candidates. The R& D team has also promised that they would wholeheartedly work towards making a successful vaccine very soon and make it available to developing countries at affordable prices.

Both companies say they hope this will be the beginning of a long-term partnership and is a model for how the public and private sectors can work together. The private sector has an immense amount of knowledge, resources and expertise, and they say that an innovative partnership such as this are essential to tackle global health challenges. Hilary Benn, UK Secretary of State for International Development has stressed on the need of an an AIDS vaccine in the fight against disease an d extreme poverty in the developing world, particularly in Africa and also says that such types of collaboration between the public and private sectors is critical for enhancing the research and development of new vaccines against the world’s most devastating infectious diseases.


Related medicine news :

1. Risk Of Developing Arthritis
2. Developing HIV fighter
3. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
4. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
5. Men Who at Risk Of Developing Prostate Cancer
6. Identifying The Risks Of Developing Schizophrenia
7. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
8. Cancer Patients At A Greater Risk Of Developing Blood Clots
9. Young Smokers at Increased Risk Of Developing a Heart Attack
10. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ ... list of its hemorrhoid ointment to its website. , “Our goal is simple:” ... suffering from hemorrhoids. Adding the comparison chart and ingredient list allows our customers ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood sugar ... and adults, according to a new study by researchers at the School of Public ... and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in Public ...
(Date:11/30/2015)... ... November 30, 2015 , ... The recently published ... Data System (NPDS) reveals that in 2014, someone called a poison center about ... million of which were human exposure cases. , The American Association of Poison ...
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... 30, 2015 , ... Medicalis, a leading developer of enterprise-scale ... America (RSNA) annual meeting, being held November 29 – December 3, 2015, that ... the company has completed installations for Integrated Delivery Network (IDN) customers such as ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... --  Royal Philips  (NYSE: PHG ; AEX: ... a fully integrated, consultative approach to enhance radiology ... management approaches that combine imaging systems, services, informatics ... delivery and reduce costs. Making its debut at ... Annual Meeting (RSNA) in Chicago ...
(Date:11/30/2015)... DULLES, Va. , Nov. 30, 2015  IBA ... the manufacture and distribution of radiopharmaceuticals, announced that as ... Zevacor Pharma, Inc. (Zevacor Pharma). The decision to rebrand ... of the firm as well as its close relationship ... owned by Illinois Health and Science (IHS). ...
(Date:11/30/2015)... BOCA RATON, Fla. , Nov. 30, ... of Public Research (the Institute) announced today that ... , a medical device start-up company with technology developed ... creation based on publicly-funded research, and bridges early funding ... -based universities and research institutions. ...
Breaking Medicine Technology: